ID

45749

Beschreibung

Principal Investigator: MeSH: Pediatrics https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001165 The Center for Applied Genomics (CAG) is a specialized Center of Emphasis at the Children's Hospital of Philadelphia (CHOP) with the primary goal of translating basic research findings to medical innovations. The mission of CAG is to develop new and better ways to diagnose and treat children affected by rare and complex medical disorders. We aim to discover genetic causes for the most prevalent diseases of childhood including asthma, autism, diabetes, epilepsy, obesity, schizophrenia, pediatric cancer, and a range of rare diseases. Ultimately, our objective is to generate new diagnostic tests and to guide physicians to the most appropriate therapies. The CAG is one of the world's largest genetics research programs in pediatrics, and the only center at a pediatric hospital to have established a large-scale biobank of genotyped samples. The electronic Medical Records and Genomics (eMERGE) Network is a consortium of 9 clinical sites with EMR linked DNA biobanks, including Northwestern University and its NUgene biobank, funded by the NHGRI (National Human Genome Research Institute) to investigate the use of electronic medical record systems for genomic research. The goal of eMERGE is to conduct genome-wide association studies in approximately 100,000 individuals using EMR-derived phenotypes and DNA from linked biorepositories. Using electronic phenotyping methods, the consortium has been and is using DNA samples from all participating sites to explore the genetic determinants of approximately 80 phenotypes, including both diseases and traits, for which the electronic phenotyping algorithms have or are being published on PheKB.org.

Link

dbGaP-study=phs001165

Stichworte

  1. 04.06.23 04.06.23 - Chiara Middel
Rechteinhaber

Hakon Hakonarson, MD, PhD

Hochgeladen am

4. Juni 2023

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

dbGaP phs001165 eMERGE: Children's Hospital of Philadelphia - WGS

Eligibility Criteria

Inclusion and exclusion criteria
Beschreibung

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Inclusion Criteria: Participants were selected for whole genome sequencing for use in eMERGE, based on the following inclusion criteria:
Beschreibung

Elig.phs001165.v1.p1.1

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0242802
UMLS CUI [1,2]
C3640076
UMLS CUI [1,3]
C1512693
UMLS CUI [1,4]
C1516637
Participants agreed to be re-contacted for future research.
Beschreibung

Elig.phs001165.v1.p1.2

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600109
UMLS CUI [1,2]
C1522577
UMLS CUI [1,3]
C0332158
UMLS CUI [1,4]
C0681850
UMLS CUI [1,5]
C0016884
UMLS CUI [1,6]
C0008972
Participants were able to provide signed informed consent. For participants 8-18 years, assent and parental approval were required.
Beschreibung

Elig.phs001165.v1.p1.3

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0600109
UMLS CUI [1,3]
C1999230
UMLS CUI [1,4]
C0021430
UMLS CUI [2,1]
C0205653
UMLS CUI [2,2]
C0030551
UMLS CUI [2,3]
C1999230
UMLS CUI [2,4]
C0021430
Participants were proficient in the English language.
Beschreibung

Elig.phs001165.v1.p1.4

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1145677
UMLS CUI [1,2]
C0376245
Exclusion Criteria:
Beschreibung

Elig.phs001165.v1.p1.5

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0680251
Anxiety to the point of inability to comply with neurocognitive battery or neuroimaging study.
Beschreibung

Elig.phs001165.v1.p1.6

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003467
UMLS CUI [1,2]
C1299582
UMLS CUI [1,3]
C0525058
UMLS CUI [1,4]
C0451331
UMLS CUI [1,5]
C0679575
UMLS CUI [1,6]
C0008976
Medical disorders that may impact the results and measurements obtained during neurodevelopmental evaluations or neuroimaging (e.g., seizures, significant head trauma, CNS tumor, infection) or visual performance (e.g., blindness).
Beschreibung

Elig.phs001165.v1.p1.7

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C4049986
UMLS CUI [1,3]
C1274040
UMLS CUI [1,4]
C0242485
UMLS CUI [1,5]
C1301820
UMLS CUI [1,6]
C0347984
UMLS CUI [1,7]
C1535926
UMLS CUI [1,8]
C1261322
UMLS CUI [1,9]
C0679575
Conditions interfering with MR scanning including metallic inserts, orthopedic circumstances, and pregnancy, determined by a urine test in females of child bearing potential.
Beschreibung

Elig.phs001165.v1.p1.8

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0024485
UMLS CUI [1,4]
C3693688
UMLS CUI [1,5]
C0029354
UMLS CUI [1,6]
C0430056
UMLS CUI [1,7]
C3831118
UMLS CUI [1,8]
C0032961

Ähnliche Modelle

Eligibility Criteria

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs001165.v1.p1.1
Item
Inclusion Criteria: Participants were selected for whole genome sequencing for use in eMERGE, based on the following inclusion criteria:
boolean
C0242802 (UMLS CUI [1,1])
C3640076 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,3])
C1516637 (UMLS CUI [1,4])
Elig.phs001165.v1.p1.2
Item
Participants agreed to be re-contacted for future research.
boolean
C0600109 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
C0332158 (UMLS CUI [1,3])
C0681850 (UMLS CUI [1,4])
C0016884 (UMLS CUI [1,5])
C0008972 (UMLS CUI [1,6])
Elig.phs001165.v1.p1.3
Item
Participants were able to provide signed informed consent. For participants 8-18 years, assent and parental approval were required.
boolean
C0085732 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C1999230 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
C0205653 (UMLS CUI [2,1])
C0030551 (UMLS CUI [2,2])
C1999230 (UMLS CUI [2,3])
C0021430 (UMLS CUI [2,4])
Elig.phs001165.v1.p1.4
Item
Participants were proficient in the English language.
boolean
C1145677 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Elig.phs001165.v1.p1.5
Item
Exclusion Criteria:
boolean
C0680251 (UMLS CUI [1,1])
Elig.phs001165.v1.p1.6
Item
Anxiety to the point of inability to comply with neurocognitive battery or neuroimaging study.
boolean
C0003467 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0451331 (UMLS CUI [1,4])
C0679575 (UMLS CUI [1,5])
C0008976 (UMLS CUI [1,6])
Elig.phs001165.v1.p1.7
Item
Medical disorders that may impact the results and measurements obtained during neurodevelopmental evaluations or neuroimaging (e.g., seizures, significant head trauma, CNS tumor, infection) or visual performance (e.g., blindness).
boolean
C0012634 (UMLS CUI [1,1])
C4049986 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C0242485 (UMLS CUI [1,4])
C1301820 (UMLS CUI [1,5])
C0347984 (UMLS CUI [1,6])
C1535926 (UMLS CUI [1,7])
C1261322 (UMLS CUI [1,8])
C0679575 (UMLS CUI [1,9])
Elig.phs001165.v1.p1.8
Item
Conditions interfering with MR scanning including metallic inserts, orthopedic circumstances, and pregnancy, determined by a urine test in females of child bearing potential.
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
C3693688 (UMLS CUI [1,4])
C0029354 (UMLS CUI [1,5])
C0430056 (UMLS CUI [1,6])
C3831118 (UMLS CUI [1,7])
C0032961 (UMLS CUI [1,8])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video